Washingtonians could soon be spending less for insulin. A new bill to lower insulin costs has been introduced by Sen. Karen Keiser, D-Des Moines, prior to the beginning of the 2022 legislative session. Senate Bill 5546 would put a $35 price cap on a 30-day supply of the life-saving drug for diabetic patients in Washington.

Read more here.